Table 1. Biopsy sites, sampling methods and pathological types for the 10 patients with cancer.
No. | Patient | Gender | Age (years) | Puncture site | Sampling method | Pathological type |
---|---|---|---|---|---|---|
1 | 010000* | Male | 64 | Lung | Cutting puncture | Small cell carcinoma |
2 | 010024 | Male | 64 | Lung | Cutting puncture | Squamous cell carcinoma |
3 | 010031 | Male | 46 | Lung | Cutting puncture | Small cell carcinoma |
4 | 010034 | Male | 55 | Lung | Cutting puncture | Adenocarcinoma |
5 | 010027* | Male | 60 | Liver | Cutting puncture | Adenocarcinoma |
6 | 010023 | Male | 52 | Lung | Needle aspiration | Adenocarcinoma |
7 | 010026* | Male | 78 | Lung | Needle aspiration | Small cell carcinoma |
8 | 010028 | Female | 76 | Lung | Needle aspiration | Adenocarcinoma |
9 | 010032* | Male | 74 | Lung | Needle aspiration | Squamous cell carcinoma |
10 | 010033 | Male | 68 | Lung | Needle aspiration | Adenocarcinoma |
Asterisks indicate successfully established PDTX.